Gastro-oesophageal Junction Cancer

Gastro-oesophageal junction (GOJ) cancer, also known as oesopho gastric junctional cancer, is a rare type of malignancy developing from the gastro-oesophageal junction, the area where the stomach and the oesophagus (food pipe) meet. This type of cancer is often difficult to diagnose, and may be misdiagnosed as stomach or oesophageal cancer. 

GOJ cancers are generally more common in men, and tend to be diagnosed over the age of 55. However, anyone can develop this disease. 

Types of Gastro-oesophageal Junction Cancers 

There are three types of GOJ cancers which can be categorised by their location. As these tumours are rare, research is still being conducted to determine the prevalence of each subtype. 

Type 1 GOJ Cancers 

Type 1 GOJ cancers are defined as malignancies in the gastro-oesophageal junction that have spread from above (i.e. the lower portion of the oesophagus). The centre of the tumour is generally located approximately 1-5cm above the gastro-oesophageal junction. 

Type 2 GOJ Cancers 

Type 2 GOJ cancers are defined as malignancies that originate in the gastro-oesophageal junction. The centre of the tumour is generally located approximately 1cm above and 2cm below the gastro-oesophageal junction. 

Type 3 GOJ Cancers 

Type 3 GOJ cancers are defined as malignancies in the gastro-oesophageal junction that have spread from below (i.e. the upper portion of the stomach). The centre of the tumour is generally located approximately 2-5cm below the gastro-oesophageal junction. 

Treatment 

If GOJ cancer is detected, it will be staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. 

Cancers can be staged using the TNM staging system: 

  • T (tumour) indicates the size and depth of the tumour. 
  • N (node) indicates whether the cancer has spread to nearby lymph nodes. 
  • M (metastasis) indicates whether the cancer has spread to other parts of the body. 

This system can also be used in combination with a numerical value, from stage 0-IV: 

  • Stage 0: this stage describes cancer cells in the place of origin (or ‘in situ’) that have not spread to nearby tissue. 
  • Stage I: cancer cells have begun to spread to nearby tissue. It is not deeply embedded into nearby tissue and had not spread to lymph nodes. This stage is also known as early-stage cancer. 
  • Stage II: cancer cells have grown deeper into nearby tissue. Lymph nodes may or may not be affected. This is also known as localised cancer. 
  • Stage III: the cancer has become larger and has grown deeper into nearby tissue. Lymph nodes are generally affected at this stage. This is also known as localised cancer. 
  • Stage IV: the cancer has spread to other tissues and organs in the body. This is also known as advanced or metastatic cancer. 

Cancers can also be graded based on the rate of growth and how likely they are to spread: 

  • Grade I: cancer cells present as slightly abnormal and are usually slow growing. This is also known as a low-grade tumour. 
  • Grade II: cancer cells present as abnormal and grow faster than grade-I tumours. This is also known as an intermediate-grade tumour.  
  • Grade III: cancer cells present as very abnormal and grow quickly. This is also known as a high-grade tumour.  

Once your tumour has been staged and graded, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.  

Treatment is dependent on several factors, including location, stage of disease and overall health.  

Treatment options for GOJ cancers may include: 

  • Surgery, potentially including: 
    • Gastrectomy.
    • Oesophagectomy.
    • Lymphadenectomy.
    • Surgery to insert a feeding tube, such as a gastronomy tube (G-tube) or nasogastric tube (NG tube).
    • Oesophagogastrectomy.
  • Chemotherapy. 
  • Radiation therapy. 
  • Targeted therapy. 
  • Immunotherapy. 
  • Clinical trials. 
  • Palliative care.

Risk factors

While the cause of GOJ cancer remains unknown, some of the following factors may increase the risk of you developing the disease: 

  • Being obese. 
  • Having pre-existing conditions of the gastrointestinal tract (e.g., Barrett’s oesophagus or gastro-oesophageal reflux disease (GORD)). 
  • Previous infection with helicobacter pylori (H. pylori).  

Not everyone with these risk factors will develop the disease, and some people who have the disease may have none of these risk factors. See your general practitioner (GP) if you are concerned. 

Symptoms 

The symptoms of GOJ cancers may include a combination of stomach cancer symptoms and oesophageal cancer. 

Symptoms of Stomach Cancer 

Symptoms of a stomach cancer may include: 

  • Unexplained weight loss and/or loss of appetite. 
  • Difficulties swallowing. 
  • Indigestion, which may carry its own set of symptoms: 
    • Abdominal pain/burning. 
    • Heartburn. 
    • Frequent burping. 
    • Reflux. 
  • Nausea and/or vomiting. 
  • Abdominal pain. 
  • Feeling full after eating small quantities of food. 
  • Abdominal swelling and/or bloating. 
  • Fatigue. 
  • Anaemia. 
  • Vomit with blood in it. 
  • Discoloured stools. 

Symptoms of Oesophageal Cancer 

Symptoms of oesophageal cancers may include: 

  • Difficulty swallowing. 
  • New heartburn or reflux. 
  • Worsening indigestion. 
  • Food or liquids ‘catching’ in the throat or choking episodes when swallowing. 
  • Pain when swallowing. 
  • Unexplained weight loss. 
  • Unexplained loss of appetite. 
  • Discomfort in abdomen. 
  • Fatigue. 
  • Vomit or stool with blood. 

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.  

Diagnosis

If your doctor suspects you have a GOJ cancer, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Imaging tests, potentially including:
    • CT (computed tomography) scan.
    • PET (positron emission tomography) scan.
    • Endoscopic ultrasound.
  • Blood tests.
  • Endoscopy.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.